Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Seagen, a wholly owned subsidiary of Pfizer
Ignace Vergote; Antonio González-Martín; Keiichi Fujiwara; Elsa Kalbacher; Andrea Bagaméri; Sharad Ghamande; Jung-Yun Lee; Susana Banerjee; Fernando Cotait Maluf; Domenica Lorusso; Kan Yonemori; Els Van Nieuwenhuysen; Luis Manso; Linn Woelber; Anneke Westermann; Allan Covens; Kosei Hasegawa; Byoung-Gie Kim; Miriam Raimondo; Maria Bjurberg; Felipe Melo Cruz; Antoine Angelergues; David Cibula; Lisa Barraclough; Ana Oaknin; Christine Gennigens; Leo Nicacio; Melinda Siew Leng Teng; Elizabeth Whalley; Ibrahima Soumaoro; Brian M Slomovitz; innovaTV 301/ENGOT-cx12/GOG-3057 Collaborators